Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.

The American University law review - 1 Jan 2013

Bergin Christopher

Abstract excerpt

Ass'n for Molecular Pathology v. U.S. Patent & Trade Office sent shockwaves through the legal community, when the U.S. District Court for the Southern District of New York rejected a series of patents held by Myriad Genetics, Inc. The court invalidated all of Myriad's compositional patents for human genes and its method patents for diagnosing genetic predispositions to breast cancer. While commentators have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Molecular Diagnostic Techniques

Share to Patents as Topic

Share to Precision Medicine

Share to United States

Source

Identifiers

PMID: 25335200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.PMID 25335200Read ↗

Gene patents at the Supreme Court: Association for Molecular Pathology v. Myriad GeneticsSemantic proximity Read ↗

Law-medicine interfacing: patenting of human genes and mutations.Semantic proximity Read ↗

Myriad Genetics: In the eye of the policy storm.Semantic proximity Read ↗

Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.Semantic proximity Read ↗

Your money or your life: will gene testing tell insurance companies anything about diseases they don't know already?Semantic proximity Read ↗

Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.Semantic proximity Read ↗

How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical care.Semantic proximity Read ↗

Patents, genomics, research, and diagnostics.Semantic proximity Read ↗

The DNA hard sell: a gene test may lead to discrimination.Semantic proximity Read ↗

The fate and future of patents on human genes and genetic diagnostic methods.Semantic proximity Read ↗

Law and Science Collide Over Human Gene PatentsSemantic proximity Read ↗

Patents in Genomics and Human GeneticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.